Medline (MDLN) Interest Expenses (2024 - 2026)

Medline (MDLN) has 3 years of Interest Expenses data on file, last reported at $701.0 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 187.3% year-over-year to $701.0 million in Q1 2026; TTM through Mar 2026 was $701.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $945.0 million, down 17.4% from the prior year.
• Interest Expenses for Q1 2026 stood at $701.0 million, up from $195.0 million in the prior quarter.
• Over the last five years, Interest Expenses for MDLN reached as high as $701.0 million in Q1 2026 and fell as low as $4.0 million in Q4 2024.
• Historically, Interest Expenses has averaged $286.0 million across 3 years, with a median of $219.5 million in 2025.
• Across the five-year window, Interest Expenses jumped 4775.0% in 2025 and surged 187.3% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $4.0 million in 2024, then soared by 4775.0% to $195.0 million in 2025, then surged by 259.49% to $701.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $701.0 million in Q1 2026, $195.0 million in Q4 2025, and $244.0 million in Q1 2025.